---
$id: https://graph.org.ai/products/commodity/51144016
$type: Product
source: UNSPSC
code: "51144016"
title: "Morforex"
class: "51144000"
classTitle: "Stimulant or anorexiant amines"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Morforex

**UNSPSC Code**: 51144016
**Class**: [Stimulant or anorexiant amines](Stimulant or anorexiant amines.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) O9J6ITY8UX. European Medicines Agency schedules Morforex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09066MIG. Morforex generally arises in the molecular formula C15H24N2O. The term MORFOREX is an International Non-Proprietary Name or INN. MORFOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule morforex under HS 29349990 and SITC 51579. As of Q4 2014, MORFOREX remains US FDA's Preferred Term for this commodity. Morforex bears US NLM identifiers UMLS ID C1881900 and NCI Concept Code C66195. SMILES: O1CCN(CCNC(CC2CCCCC2)C)CC1.

